Cardinal Health Inc
XBER:CLH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its 3-Year Average (9.4), the stock would be worth €170.75 (3% downside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 9.7 | €176.25 |
0%
|
| 3-Year Average | 9.4 | €170.75 |
-3%
|
| 5-Year Average | 9.4 | €170.75 |
-3%
|
| Industry Average | 23 | €418.31 |
+137%
|
| Country Average | 23.2 | €421.74 |
+139%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Cardinal Health Inc
XBER:CLH
|
47.9B EUR | 9.7 | 28.8 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
101.2B USD | 10.7 | 23.3 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.7B USD | 18.4 | 37.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
60.6B USD | 18.4 | 37.3 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32B AUD | 62.3 | 35.2 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.8B CNY | 19.5 | 11 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.5B USD | 22 | 21.5 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.8B CNY | 159.2 | 20.7 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | -285 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
58.6B HKD | 0.5 | 7.2 | |
| DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 19.8 | -5.1 |
Market Distribution
| Min | 0 |
| 30th Percentile | 15.4 |
| Median | 23.2 |
| 70th Percentile | 35.1 |
| Max | 3 178 983.5 |
Other Multiples
Cardinal Health Inc
Glance View
Cardinal Health Inc., a formidable player in the healthcare sector, operates with the intricacy and precision of a well-orchestrated symphony. At its core, the company thrives on the distribution of pharmaceuticals and medical products, deftly weaving through the complexities of the healthcare supply chain. Cardinal Health serves as a lifeline connecting manufacturers on one end to healthcare providers and pharmacies on the other, ensuring that vital medications and supplies reach those in need efficiently. With a robust logistics network and sophisticated information systems, the company navigates a sprawling array of over 46,000 products, delivering them with diligence to hospitals, clinics, and retail pharmacies across the globe. In its pursuit of business ingenuity, Cardinal Health has expanded its horizons beyond distribution. The company ventures into the vibrant realm of medical and surgical products, offering an array of services that cater to clinical laboratories, ambulatory surgery centers, and more. This diversification not only amplifies its revenue streams but also aligns with its strategic goal of building a comprehensive healthcare ecosystem. Cardinal Health earns its income by capitalizing on a combination of service fees, margins from product sales, and a spectrum of value-added solutions. This intricate blend allows the company to maintain a competitive edge in an era where healthcare demands are ever-evolving and cost-efficiency is paramount. This finely tuned business model is what enables Cardinal Health to sustain its economic vitality and continue its transformative impact on healthcare delivery.